Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis

Abstract Background Ganoderma (Lingzhi in Chinese) has shown good clinical outcomes in the treatment of insomnia, restlessness, and palpitation. However, the mechanism by which Ganoderma ameliorates insomnia is unclear. We explored the mechanism of the anti-insomnia effect of Ganoderma using systems...

Full description

Bibliographic Details
Main Authors: Yu Qiu, Zhu-Jun Mao, Ye-Ping Ruan, Xin Zhang
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Microbiology
Subjects:
Online Access:https://doi.org/10.1186/s12866-021-02361-5
_version_ 1819003822614249472
author Yu Qiu
Zhu-Jun Mao
Ye-Ping Ruan
Xin Zhang
author_facet Yu Qiu
Zhu-Jun Mao
Ye-Ping Ruan
Xin Zhang
author_sort Yu Qiu
collection DOAJ
description Abstract Background Ganoderma (Lingzhi in Chinese) has shown good clinical outcomes in the treatment of insomnia, restlessness, and palpitation. However, the mechanism by which Ganoderma ameliorates insomnia is unclear. We explored the mechanism of the anti-insomnia effect of Ganoderma using systems pharmacology from the perspective of central-peripheral multi-level interaction network analysis. Methods The active components and central active components of Ganoderma were obtained from the TCMIP and TCMSP databases, then screened to determine their pharmacokinetic properties. The potential target genes of these components were identified using the Swiss Target Prediction and TCMSP databases. The results were matched with the insomnia target genes obtained from the GeneCards, OMIM, DisGeNET, and TCMIP databases. Overlapping targets were subjected to multi-level interaction network analysis and enrichment analysis using the STRING, Metascape, and BioGPS databases. The networks analysed were protein-protein interaction (PPI), drug-component-target gene, component-target gene-organ, and target gene-extended disease; we also performed gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Results In total, 34 sedative-hypnotic components (including 5 central active components) were identified, corresponding to 51 target genes. Multi-level interaction network analysis and enrichment analysis demonstrated that Ganoderma exerted an anti-insomnia effect via multiple central-peripheral mechanisms simultaneously, mainly by regulating cell apoptosis/survival and cytokine expression through core target genes such as TNF, CASP3, JUN, and HSP90αA1; it also affected immune regulation and apoptosis. Therefore, Ganoderma has potential as an adjuvant therapy for insomnia-related complications. Conclusion Ganoderma exerts an anti-insomnia effect via complex central-peripheral multi-level interaction networks.
first_indexed 2024-12-20T23:27:07Z
format Article
id doaj.art-6bb41babd1664ea68ca9851e68b95d75
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-12-20T23:27:07Z
publishDate 2021-10-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-6bb41babd1664ea68ca9851e68b95d752022-12-21T19:23:22ZengBMCBMC Microbiology1471-21802021-10-0121111610.1186/s12866-021-02361-5Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysisYu Qiu0Zhu-Jun Mao1Ye-Ping Ruan2Xin Zhang3School of Pharmaceutical Sciences, Zhejiang Chinese Medical UniversitySchool of Pharmaceutical Sciences, Zhejiang Chinese Medical UniversitySchool of Pharmaceutical Sciences, Zhejiang Chinese Medical UniversitySchool of Pharmaceutical Sciences, Zhejiang Chinese Medical UniversityAbstract Background Ganoderma (Lingzhi in Chinese) has shown good clinical outcomes in the treatment of insomnia, restlessness, and palpitation. However, the mechanism by which Ganoderma ameliorates insomnia is unclear. We explored the mechanism of the anti-insomnia effect of Ganoderma using systems pharmacology from the perspective of central-peripheral multi-level interaction network analysis. Methods The active components and central active components of Ganoderma were obtained from the TCMIP and TCMSP databases, then screened to determine their pharmacokinetic properties. The potential target genes of these components were identified using the Swiss Target Prediction and TCMSP databases. The results were matched with the insomnia target genes obtained from the GeneCards, OMIM, DisGeNET, and TCMIP databases. Overlapping targets were subjected to multi-level interaction network analysis and enrichment analysis using the STRING, Metascape, and BioGPS databases. The networks analysed were protein-protein interaction (PPI), drug-component-target gene, component-target gene-organ, and target gene-extended disease; we also performed gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Results In total, 34 sedative-hypnotic components (including 5 central active components) were identified, corresponding to 51 target genes. Multi-level interaction network analysis and enrichment analysis demonstrated that Ganoderma exerted an anti-insomnia effect via multiple central-peripheral mechanisms simultaneously, mainly by regulating cell apoptosis/survival and cytokine expression through core target genes such as TNF, CASP3, JUN, and HSP90αA1; it also affected immune regulation and apoptosis. Therefore, Ganoderma has potential as an adjuvant therapy for insomnia-related complications. Conclusion Ganoderma exerts an anti-insomnia effect via complex central-peripheral multi-level interaction networks.https://doi.org/10.1186/s12866-021-02361-5GanodermaInsomniaSystems pharmacologyCentralPeripheral
spellingShingle Yu Qiu
Zhu-Jun Mao
Ye-Ping Ruan
Xin Zhang
Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
BMC Microbiology
Ganoderma
Insomnia
Systems pharmacology
Central
Peripheral
title Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
title_full Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
title_fullStr Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
title_full_unstemmed Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
title_short Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis
title_sort exploration of the anti insomnia mechanism of ganoderma by central peripheral multi level interaction network analysis
topic Ganoderma
Insomnia
Systems pharmacology
Central
Peripheral
url https://doi.org/10.1186/s12866-021-02361-5
work_keys_str_mv AT yuqiu explorationoftheantiinsomniamechanismofganodermabycentralperipheralmultilevelinteractionnetworkanalysis
AT zhujunmao explorationoftheantiinsomniamechanismofganodermabycentralperipheralmultilevelinteractionnetworkanalysis
AT yepingruan explorationoftheantiinsomniamechanismofganodermabycentralperipheralmultilevelinteractionnetworkanalysis
AT xinzhang explorationoftheantiinsomniamechanismofganodermabycentralperipheralmultilevelinteractionnetworkanalysis